The American College of Cardiology urges heart disease patients to get vaccinated against respiratory illnesses like RSV and COVID-19, contradicting recent U.S. vaccine access restrictions.
The American College of Obstetricians and Gynecologists has released updated guidance recommending COVID-19, influenza, and RSV vaccinations for pregnant women. These vaccines are shown to protect both mothers and infants from severe respiratory illnesses. Discover why vaccination is essential for a healthy pregnancy.
A new initiative, the Vaccine Integrity Project, led by experts including Dr. Mike Osterholm, aims to provide accurate information on vaccines amidst rising misinformation. Tune in to their YouTube session for credible insights on COVID, RSV, and influenza immunizations.
A groundbreaking study reveals that streaked shearwaters have a unique bathroom ritual, pooping midair every 4 to 10 minutes, offering insights into their behavior and potential impacts on coastal ecosystems.
AstraZeneca has unveiled an at-home delivery option for its FluMist nasal spray flu vaccine, allowing parents to vaccinate their children without leaving home. This groundbreaking move aims to boost vaccination rates amid declining flu shot coverage.
The CDC has officially ended its emergency response to H5N1 bird flu due to a significant drop in cases and no human infections reported since February 2025. Experts weigh in on future risks.
In a surprising move, the HHS has terminated a $590 million contract with Moderna for H5 avian influenza vaccine development, raising alarms among health experts amidst rising H5N1 threats.
This flu season has seen the highest number of pediatric deaths since the swine flu pandemic, with alarming statistics emerging from the CDC. Experts warn of a potential undercount and emphasize the need for increased vaccination rates among children.
The U.S. Department of Health and Human Services is on a bold mission to develop a universal flu vaccine within four years, a project that could revolutionize how we combat influenza and prepare for future pandemics. Funded by $500 million, this initiative aims for FDA approval by 2029, with clinical trials starting soon. Experts weigh in on the challenges and potential of this ambitious project.
Experts warn that the H5N1 bird flu virus, which has already infected humans and mammals, continues to evolve. As outbreaks persist, the potential for a pandemic looms closer than ever. Are we prepared for what's next?
